TFF2 and neoplasm: Carcinoma-produced MMP1 activates neuronal protease-activated receptor 1 (PAR1) and induces substance P (SP) release, activating carcinoma neurokinin 1 receptor (NK1R), which plays a pivotal role in tumor progression and PNI [42,56].